Fischer Medical Ventures Converts 2.05 Crore Warrants, Receives ₹35.99 Crore

The company allotted 2.05 crore equity shares at ₹23.40 each following warrant conversion by promoters and a non-promoter, receiving ₹35.99 crore in remaining exercise consideration. Context: extends the staged warrant-conversion process and reduces the reported overhang.